Sudheer K Vuyyuru
Overview
Explore the profile of Sudheer K Vuyyuru including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abushamma S, Yadete T, Nero N, Falloon K, Parker C, Abreu M, et al.
J Crohns Colitis
. 2025 Mar;
PMID: 40066499
Background And Aims: Over 10% of patients with Crohn's disease require permanent ileostomy. We aimed to summarize the existing data on diagnosis, definitions of recurrence, and management of Crohn's disease...
2.
Sedano R, Solitano V, Vuyyuru S, Yuan Y, Hanzel J, Ma C, et al.
Therap Adv Gastroenterol
. 2025 Feb;
18:17562848251321915.
PMID: 39996136
Integrating artificial intelligence (AI) into clinical trials for inflammatory bowel disease (IBD) has potential to be transformative to the field. This article explores how AI-driven technologies, including machine learning (ML),...
3.
Vuyyuru S, Ma C, Nguyen T, Zou G, Peyrin-Biroulet L, Danese S, et al.
EClinicalMedicine
. 2024 Dec;
78:102980.
PMID: 39659444
[This corrects the article DOI: 10.1016/j.eclinm.2024.102621.].
4.
Bajaj A, Markandey M, Samal A, Goswami S, Vuyyuru S, Mohta S, et al.
Gut Pathog
. 2024 Nov;
16(1):65.
PMID: 39511674
Background/aims: Crohn's disease (CD) and intestinal tuberculosis (ITB) are gastrointestinal (GI) inflammatory disorders with overlapping clinical presentations but diverging etiologies. The study aims to decipher CD and ITB-associated gut dysbiosis...
5.
Ndzo J, Vuyyuru S, Trimble T, Yan K, Figueredo G, Moran G
Clin Nutr ESPEN
. 2024 Oct;
64:290-295.
PMID: 39423922
Background & Aims: Incidence of obesity and Crohn's disease (CD) is increasing globally. Therefore, understanding any associations between adiposity and disease phenotype is crucial. We aimed explore the relationship between...
6.
Sharma P, Putambekar V, Kumar P, Thomas D, Vuyyuru S, Kante B, et al.
Indian J Med Res
. 2024 Oct;
160(1):61-69.
PMID: 39382506
Background & objectives Crohn's disease (CD) is associated with a higher risk of malignancy, which is attributed to disease behaviour and the usage of immunosuppressants. The burden of malignancy in...
7.
Mundhra S, Madan D, Golla R, Sahu P, Vuyyuru S, Kante B, et al.
J Crohns Colitis
. 2024 Jun;
18(11):1870-1878.
PMID: 38881153
Introduction: Overall, 30-40% patients with acute severe ulcerative colitis [ASUC] fail intravenous [IV] steroids, requiring medical rescue therapy/colectomy. Low baseline albumin predicts steroid non-response, and exclusive enteral nutrition [EEN] has...
8.
Vuyyuru S, Ma C, Nguyen T, Zou G, Peyrin-Biroulet L, Danese S, et al.
EClinicalMedicine
. 2024 May;
72:102621.
PMID: 38726222
Background: Disease extent in Ulcerative Colitis (UC) has prognostic implications for disease course. It is unclear whether the efficacy of medical therapies for moderate to severely active UC vary according...
9.
Vuyyuru S, Jairath V
Indian J Gastroenterol
. 2024 Jan;
43(1):9-14.
PMID: 38189896
No abstract available.
10.
Vuyyuru S, Nguyen T, Murad M, Narula N, Bessissow T, Zou G, et al.
Clin Gastroenterol Hepatol
. 2024 Jan;
22(6):1190-1199.e15.
PMID: 38185396
Background & Aims: We conducted a network meta-analysis to compare the efficacy of advanced therapies for achieving endoscopic outcomes in patients with moderate-to-severely active Crohn's disease. Methods: MEDLINE, Embase, and...